Documentation Centre

 

 

  of 1401 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Closing the remaining evidence gap: Randomized controlled trial data to support statin therapy for low-density lipoprotein ≥190 mg/dL. Circulation. 2017;136:1892-1894 February 21, 2018 Closing the remaining evidence gap: Randomized controlled trial data to support statin therapy for low-density lipoprotein ≥190 mg/dL. Circulation. 2017;136:1892-1894 Watson KE, Fonarow GC Key Publications
Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification. Am Heart J. 2017;193:95-103 February 20, 2018 Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification. Am Heart J. 2017;193:95-103 Akintoye E, Briasoulis A, Afonso L Key Publications
Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017;136:1878-1891 February 20, 2018 Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017;136:1878-1891 Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, Ford I, Ray KK Key Publications
Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles. Eur J Clin Nutr. 2017;71:1297-1302 February 13, 2018 Effect of diets rich in either saturated fat or n-6 polyunsaturated fatty acids and supplemented with long-chain n-3 polyunsaturated fatty acids on plasma lipoprotein profiles. Eur J Clin Nutr. 2017;71:1297-1302 Dias CB, Amigo N, Wood LG, Correig X, Garg ML Key Publications
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial. J Lipid Res. 2017;58:2180-2187 February 09, 2018 Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial. J Lipid Res. 2017;58:2180-2187 Koopal C, Marais AD, Westerink J, van der Graaf Y, Visseren FLJ Key Publications
Very low LDL-cholesterol concentrations achieved: which target is next? Lancet. 2017;390:1930-1931 February 07, 2018 Very low LDL-cholesterol concentrations achieved: which target is next? Lancet. 2017;390:1930-1931 Hovingh GK, Boekholdt SM, Stroes ES Key Publications
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. Lancet. 2017;390:1962-1971 February 07, 2018 Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. Lancet. 2017;390:1962-1971 Giugliano RP, Pedersen TR, Park JG, De Ferrari GM, Gaciong ZA, Ceska R, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F, Mach F, Ott BR, Kanevsky E, Pineda AL, Somaratne R, Wasserman SM, Keech AC, Sever PS, Sabatine MS; FOURIER Investigators Key Publications
A Mendelian randomization study of metabolite profiles, fasting glucose, and type 2 diabetes. Diabetes. 2017;66:2915-2926 February 01, 2018 A Mendelian randomization study of metabolite profiles, fasting glucose, and type 2 diabetes. Diabetes. 2017;66:2915-2926 Liu J, van Klinken JB, Semiz S, van Dijk KW, Verhoeven A, Hankemeier T, Harms AC, Sijbrands E, Sheehan NA, van Duijn CM, Demirkan A Key Publications
Fatty acid metabolic remodeling during type 2 diabetes remission after bariatric surgery. Diabetes. 2017;66:2743-2755 January 31, 2018 Fatty acid metabolic remodeling during type 2 diabetes remission after bariatric surgery. Diabetes. 2017;66:2743-2755 Grenier-Larouche T, Carreau AM, Geloën A, Frisch F, Biertho L, Marceau S, Lebel S, Hould FS, Richard D, Tchernof A, Carpentier AC Key Publications
High-risk coronary atherosclerosis: is it the plaque burden, the calcium, the lipid, or something else? Circ Cardiovasc Imaging. 2017;10: e007116 January 29, 2018 High-risk coronary atherosclerosis: is it the plaque burden, the calcium, the lipid, or something else? Circ Cardiovasc Imaging. 2017;10: e007116 Maehara A, Stone GW Key Publications

  of 1401 Next page

Go to page: of